|
Chromium in Metabolic and Cardiovascular Disease
Horm Metab Res 2007 (Oct); 39 (10): 743–751
Chromium is an essential mineral that appears to have a beneficial role in the regulation of insulin action, metabolic syndrome, and cardiovascular disease. There is growing evidence that chromium may facilitate insulin signaling and chromium supplementation therefore may improve systemic insulin sensitivity. Tissue chromium levels of subjects with diabetes are lower than those of normal control subjects, and a correlation exists between low circulating levels of chromium and the incidence of type 2 diabetes. Controversy still exists as to the need for chromium supplementation.
|
|
A Scientific Review: The Role of Chromium in Insulin Resistance
The Diabetes Educator 2004; Suppl: 2–14
Chromium is an essential mineral that appears to have a beneficial role in the regulation of insulin action and its effects on carbohydrate, protein and lipid metabolism. Chromium is an important factor for enhancing insulin activity. Studies show that people with type 2 diabetes have lower blood levels of chromium than those without the disease. Insulin resistance is the common denominator in a cluster of cardiovascular disease risk factors. One out of every five Americans has metabolic syndrome. It affects 40% of people in their 60s and 70s. Insulin resistance, with or without the presence of metabolic syndrome, significantly increases the risk of cardiovascular disease. Insulin resistance is present in two serious health problems in women; polycystic ovarian syndrome (PCOS) and gestational diabetes.
|
|
The Safety and Efficacy of High-dose Chromium
Alternative Medicine Review 2002 (Jun); 7 (3): 218–235 ~ FULL TEXT
The data on the standards for chromium requirements and the safety of various chromium compounds and doses are reviewed. The 350-fold difference between the acceptable daily intake and the calculated reference dose for humans of 70 mg per day seems without precedent with respect to other nutritional minerals. Previous claims of mutagenic effects of chromium are of questionable relevance. While studies have found DNA fragmentation (clastogenic effects) by chromium picolinate, anecdotal reports of high-dose chromium picolinate toxicity are few and ambiguous. The beneficial effects of chromium on serum glucose and lipids and insulin resistance occur even in the healthy.
|
|
Interactions of Exercise Training and Lipoic Acid on Skeletal
Muscle Glucose Transport in Obese Zucker Rats
J Appl Physiol 2001 (Jul); 91 (1): 145–153
These results indicate that Exercise Training and Alpha Lipoic Acid interact in an additive fashion to improve insulin action in insulin-resistant skeletal muscle. Because the further improvement in muscle glucose transport in the combined group was not associated with additional upregulation of GLUT-4 protein or a further reduction in oxidative stress, the mechanism for this interaction must be due to additional, as yet unidentified, factors.
|
|
Chromium in the Prevention and Control of Diabetes
Diabetes Metab 2000 (Feb); 26 (1): 22–27
Chromium is an essential nutrient involved in the metabolism of glucose, insulin and blood lipids. Suboptimal dietary intake of chromium is associated with increased risk factors associated with diabetes and cardiovascular diseases. Within the past five years, chromium has been shown to improve glucose and related variables in subjects with glucose intolerance and type 1, type 2, gestational and steroid-induced diabetes. Severe neuropathy and glucose intolerance of a patient on total parenteral nutrition, who was receiving currently recommended levels of chromium, were reversed by additional supplemental chromium.
|
|
The Effects of Inorganic Chromium and Brewer's Yeast
Supplementation on Glucose Tolerance, Serum Lipids and
Drug Dosage in Individuals with Type 2 Diabetes
Saudi Med J 2000 (Sep); 21 (9): 831–837
Chromium supplementation gives better control of glucose and lipid variables while decreasing drug dosage in type 2 diabetes patients.
|
|
Chromium, Exercise, and Body Composition
Crit Rev Food Sci Nutr 2000 (Jul); 40 (4): 291–308
Chromium is an essential trace element involved in the metabolism of carbohydrates, lipids, and proteins mainly by increasing the efficiency of insulin. Chromium deficiency affects the maintenance of normal glucose tolerance and healthy lipid profiles.
|
|
Toward Practical Prevention of Type 2 Diabetes
Med Hypotheses 2000 (May); 54 (5): 786–793
Even in individuals who are unwilling to make prudent changes in their diets and sedentary habits, the administration of certain nutrients and/or drugs may help to prevent or postpone the onset of type 2 diabetes.
|
|
Elevated Intakes of Supplemental Chromium Improve Glucose and
Insulin Variables in Individuals with Type 2 Diabetes
Diabetes 1997 (Nov); 46 (11): 1786–1791
These data demonstrate that supplemental chromium had significant beneficial effects on HbA1c, glucose, insulin, and cholesterol variables in subjects with type 2 diabetes. The beneficial effects of chromium in individuals with diabetes were observed at levels higher than the upper limit of the Estimated Safe and Adequate Daily Dietary Intake.
|
|
Chromium Deficiency, Glucose Intolerance, and Neuropathy
Reversed by Chromium Supplementation in a Patient Receiving
Long-term Total Parenteral Nutrition
Am J Clin Nutr 1977 (Apr); 30 (4): 531–538
This is the first published case study identifying a chromium-diabetes relationship, and it went on to demonstrate that supplemental chromium alleviated the patient's diabetic symptoms.
|
|
More articles about Glucose Regulation
|